Related references
Note: Only part of the references are listed.Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies
Faryal Munir et al.
TRANSLATIONAL PEDIATRICS (2023)
Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes
Ning-Ning Wang et al.
JOURNAL OF CHEMINFORMATICS (2022)
Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database
Zhi-Xuan Zhou et al.
FRONTIERS IN PHARMACOLOGY (2022)
Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System（FAERS）
Zicheng Yu et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2022)
Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS
Shuang Chai et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2022)
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021
Maggie M. Chau et al.
INTERNAL MEDICINE JOURNAL (2021)
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia A Randomized Clinical Trial
Patrick A. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
Marta Weronika Lato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation
Andreas H. Groll et al.
LANCET ONCOLOGY (2021)
Managing drug-induced QT prolongation in clinical practice
Rani Khatib et al.
POSTGRADUATE MEDICAL JOURNAL (2021)
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals
Sebastian Schneeweiss et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients
Thomas Lehrnbecher et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
How I treat relapsed acute lymphoblastic leukemia in the pediatric population
Stephen P. Hunger et al.
BLOOD (2020)
Invasive fungal diseases in patients with new diagnosed acute lymphoblastic leukaemia
Marie Gruendahl et al.
MYCOSES (2020)
Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands
Anne T. M. Dittrich et al.
PEDIATRIC DRUGS (2020)
The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the UKALL2011 protocol: a multicentre retrospective study
Maeve A. O'Reilly et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Clinical Studies on Drug-Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation
Aleksi Tornio et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
Carmelo Rizzari et al.
HAEMATOLOGICA (2019)
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
Andreas H. Groll et al.
CLINICAL INFECTIOUS DISEASES (2019)
Drug-induced liver injury
Raul J. Andrade et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Voriconazole-induced QTc prolongation in a paediatric population
Y. Pasternak et al.
ACTA PAEDIATRICA (2019)
Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modelling
Jennifer E. Hibma et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Medication safety alert fatigue may be reduced via interaction design and clinical role tailoring: a systematic review
Mustafa Hussain et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2019)
Antifungal Drugs: Special Problems Treating Central Nervous System Infections
Elizabeth Dodds Ashley
JOURNAL OF FUNGI (2019)
Management of important adverse events associated with inotuzumab ozogamicin: expert panel review
Partow Kebriaei et al.
BONE MARROW TRANSPLANTATION (2018)
Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients
Edoardo Bruno Vicenzi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine
Nihal El Rouby et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfurt-Munster (I-BFM) study group
Kim Klein et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Potential drug-drug interactions in hospitalised haematological patients
Ma Angeles Fernandez de Palencia Espinosa et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2017)
Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors
I. Gueta et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Drug-drug interactions in pediatric oncology patients
T. E. Balk et al.
PEDIATRIC BLOOD & CANCER (2017)
New developments and directions in the clinical application of the echinocandins
C. C. Chang et al.
ARCHIVES OF TOXICOLOGY (2017)
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction
Mari Fihlman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Antifungal Agents Spectrum of Activity, Pharmacology, and Clinical Indications
Jeniel E. Nett et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of US Children's Hospitals
Dingwei Dai et al.
PEDIATRIC CRITICAL CARE MEDICINE (2016)
Incidence and Survival of Childhood Cancer in Korea
Hyeon Jin Park et al.
CANCER RESEARCH AND TREATMENT (2016)
P-glycoprotein and its role in drug-drug interactions
Andrew Finch et al.
Australian Prescriber (2016)
A comparison of five common drugudrug interaction software programs regarding accuracy and comprehensiveness
Raziyeh Kheshti et al.
JOURNAL OF RESEARCH IN PHARMACY PRACTICE (2016)
Azole Antifungal Inhibition of Buprenorphine, Methadone and Oxycodone In Vitro Metabolism
David E. Moody et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2015)
Potential Drug-Drug Interactions in Infant, Child, and Adolescent Patients in Children's Hospitals
James Feinstein et al.
PEDIATRICS (2015)
A 17-year experience with ALL-BFM protocol in acute lymphoblastic leukemia: Prognostic predictors and interruptions during protocol
Aida Koka et al.
LEUKEMIA RESEARCH (2014)
Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients
M. Angeles Fernandez de Palencia Espinosa et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2014)
Potential drug-drug interactions at a referral hematology-oncology ward in Iran: a cross-sectional study
Molouk Hadjibabaie et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Acute lymphoblastic leukaemia
Hiroto Inaba et al.
LANCET (2013)
Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future
Valentina Fabiano et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
Brad Moriyama et al.
MYCOSES (2012)
Retrospective survey on the off-label use of posaconazole in pediatric hematology patients
S. Cesaro et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia
Rosalin M. van Schie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Echinocandins in Children
Jill A. Hoffman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals
Mariley Perez Garcia et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter et al.
BLOOD (2010)
Time Trends and Characteristics of Childhood Cancer Among Children Age 0-14 in Shanghai
Ping-Ping Bao et al.
PEDIATRIC BLOOD & CANCER (2009)
Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients
Stephen Harnicar et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2009)
Itraconazole, a potent inhibitor of P-glycoprotein, moderately increases plasma concentrations of oral morphine
T. Heiskanen et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2008)
Trends in childhood cancer incidence in the US (1992-2004)
Amy M. Linabery et al.
CANCER (2008)
Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation
Elizabeth Roman et al.
PEDIATRIC BLOOD & CANCER (2008)
Childhood cancer in Ireland: a population-based study
M. Stack et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2007)
Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic:: importance of the Cancer registry (a population-based study)
Arturo Fajardo-Gutierrez et al.
BMC CANCER (2007)
High-dose weekly AmBisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: A pharmacokinetic study
P Mehta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Incidence of leukemias in children from El Salvador and Mexico City between 1996 and 2000:: Population-based data -: art. no. 33
JM Mejía-Aranguré et al.
BMC CANCER (2005)
Cancer incidence among children in France, 1990-1999
E Desandes et al.
PEDIATRIC BLOOD & CANCER (2004)
Increasing incidence rates of childhood malignant diseases in Sweden during the period 1960-1998
AC Dreifaldt et al.
EUROPEAN JOURNAL OF CANCER (2004)
Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine
ED Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL
L Grigull et al.
MYCOSES (2003)
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French acute Lymphoblastic Leukaemia Group (FRALLE)
J Donadieu et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
